Contact: Sinisa Grozdanic
sgrozdan@iastate.edu
515-294-4900
Iowa State University
Caption: Tacrolimus implant was developed as a result of collaborative work between ISU scientists and NICAST Ltd., an Israel-based biotechnology company).
Credit: ISU Courtesy photo
Usage Restrictions: None
Related news release: Iowa State researcher develops new treatment method for canine eye diseases